Medico Remedies Limited (MEDICO) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE630Y01024
Key metrics
- Market Cap
- ₹352 Cr
- P/E Ratio
- 25.55
- EPS
- 1.66
- Book Value
- 9.1
- P/B Ratio
- 4.79
- ROE
- 17.38%
- ROCE
- 14.72%
- Debt / Equity
- 0.25
- Net Margin
- 6.35%
- Revenue Growth
- 36.73%
- Profit Growth
- 29.94%
- Dividend Yield
- —
- 52W High
- ₹56.88
- 52W Low
- ₹30.22
- Market Cap Band
- micro cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Medico Remedies Limited
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Promoter Holding
- 69.45%
The full Medico Remedies Limited analysis
Create a free account to open the complete MEDICO deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.